This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Müller, M., Rink, K., Krause, H. et al. PTEN/MMAC1 mutations in prostate cancer. Prostate Cancer Prostatic Dis 3 (Suppl 1), S32 (2000). https://doi.org/10.1038/sj.pcan.4500457
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500457
This article is cited by
-
Complementary biobank of rodent tissue samples to study the effect of World Trade Center exposure on cancer development
Journal of Translational Medicine (2019)
-
The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice
Prostate Cancer and Prostatic Diseases (2013)
-
PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade
Modern Pathology (2013)
-
The effect Akt2 deletion on tumor development in Pten+/− mice
Oncogene (2012)
-
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Nature (2005)